FDA halts RSV vaccine trials for infants amid safety concerns
HQ Team December 11, 2024: The U.S. Food and Drug Administration (FDA) has announced a halt to all clinical trials for respiratory syncytial
Drugs
Health
Medical
Opinion
The unseen battle: My journey with sensorimotor neuropathy
Vinit Shetty December 9, 2024: We bring you here the blogs of Mr Vinit Shetty, encapsulating his remarkable journey with sensorimotor neuropathy. Though
Uncategorized
Eli Lilly to expand US facility as demand soars for diabetes, obesity medicines
Eli Lilly and Company will invest $3 billion in the US to expand its manufacturing facility to meet a rise in demand for
Drugs
Health
Pharma
Mystery disease spreading in Congo, death toll at 31: WHO says
Thirty-one people, mostly children, have died due to an undiagnosed disease in the Democratic Republic of Congo, the WHO stated
Health
Medical
Chewing xylitol gum may help reduce preterm births by 24%, study finds
Bharti Jayshankar December 9, 2024: A study conducted in Malawi suggests that chewing gum containing xylitol, a natural sugar alcohol, could significantly lower
Drugs
Medical
Pharma
AstraZeneca, Daiichi’s trial drug for lung cancer, gets US regulator’s nod
The US regulator has granted a breakthrough therapy designation to British-Swedish AstraZeneca and Japan’s Daiichi Sankyo experimental drug for treating a certain type
Climate
Research
Hundreds of scientists warn of catastrophic sea rise in Antarctica
HQ Team December 6, 2024: Over 450 polar scientists at the inaugural Australian Antarctic Research Conference, held from November 19 to 22, 2024,
Drugs
Medical
Pharma
AstraZeneca’s drug gets nod to treat limited-stage cell lung cancer patients
The US regulator has approved AstraZeneca’s blockbuster drug Imfinzi to treat adults with limited-stage cell lung cancer.
Uncategorized
Danaher’s Cepheid gets first WHO prequalification nod for TB tests
Cepheid Inc., a US molecular diagnostics company and a wholly-owned arm of Danaher Corporation has been granted WHO prequalification for its diagnostic tests
Drugs
Medical
Pharma
Amgen Inc., to invest $1 billion to build a second plant in North Carolina
Amgen Inc., a US biotechnology company, will set up a second drug manufacturing facility in North Carolina for $1 billion, according to a